Branded Drug Companies Are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation

Holman Christopher M.

首页> 外文期刊>Biotechnology Law Report >Branded Drug Companies Are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation

【24h】

Branded Drug Companies Are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation

机译：品牌毒品公司成功地宣传了孵化蜡烛诉讼中的等同性学说

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biotechnology Law Report 》 |2021年第2期| 共23页
作者
Holman Christopher M.;
展开▼
作者单位

Univ Missouri Kansas City Sch Law Law Kansas City MO 64110 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类法律 ; 生物科学 ; 生物工程学（生物技术） ;
关键词

相似文献

外文文献
中文文献
专利

1. Exploration of approaches to adjusting brand-name drug prices in Mainland of China: based on comparison and analysis of some brand-name drug prices of Mainland and Taiwan, China [J] . Weng Geng, Han Sheng, Pu Run, 中华医学杂志（英文版） . 2014 ,第012期
2. Chinese Companies Poised to Assert [J] . Audrey GUO 中国对外贸易：英文版 . 2009 ,第023期
3. Chinese Companies Poised to Assert [J] . Audrey GUO 中国对外贸易（英文版） . 2009 ,第023期
4. Assertion of the Doctrine of Equivalents in Biotechnology Litigation: About as Successful as in Other Arts [J] . Robert A. Schwartzman Intellectual property & technology law journal . 2005 ,第12期

机译：在生物技术诉讼中主张对等原则：与其他艺术一样成功
5. Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act. [J] . Grabowski HG, Kyle M, Mortimer R, Health affairs . 2011 ,第11期

机译：不断发展的品牌和仿制药竞争可能需要修订《哈奇-瓦克斯曼法》。
6. JUST ABOUT EQUIVALENT: A COMPARATIVE ANALYSIS OF THE DOCTRINES OF EQUIVALENTS IN THE UNITED STATES AND INTERNATIONAL JURISDICTIONS SHOWS THAT THE VARYING DOCTRINES ARE STRIKINGLY SIMILAR [J] . Aaron Bowling AIPLA quarterly journal . 2013 ,第3期

机译：只是关于等价物：对美国和国际管辖区中等价物范围的比较分析表明，变化中的相称之处相似
7. Interactions between Inter Partes Review and Hatch-Waxman Litigations [C] . Feng-Chi Chen, Pin-Shen Lee, Yun-Yu Huang, IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology . 2019

机译：当事人间审查与Hatch-Waxman诉讼之间的相互作用
8. The Company One Keeps: The Khadr II Litigation in its International and Comparative Legal Context [D] . Smith, Robert Leslie Desmond 2011

机译：公司一成不变：国际和比较法律背景下的Khadr II诉讼
9. Tobacco Company Efforts to Influence the Food and Drug Administration-Commissioned Institute of Medicine Report Clearing the Smoke: An Analysis of Documents Released through Litigation [O] . Crystal E. Tan, Thomas Kyriss, Stanton A. Glantz 2013

机译：烟草公司对影响食品和药物管理局委托医学研究所报告的努力：清除烟雾：通过诉讼发布的文件的分析
10. Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act. [O] . Grabowski, HG, Kyle, M, Mortimer, R, 2011

机译：不断发展的品牌和仿制药竞争可能需要修订Hatch-Waxman法案。
11. Prescription Drugs: Price Trends for Frequently Used Brand and Generic Drugs from 2000 through 2004 [R] . 2005

机译：处方药：2000年至2004年经常使用的品牌和仿制药的价格趋势

Branded Drug Companies Are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation

著录项

相似文献

相关主题

期刊订阅